As scientists, policymakers, and public health officials monitor newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), data regarding the spread of previously identified variants are important in understanding the mechanisms through which such strains become dominant. Soon after the first case of infection with the B.1.1.7 (alpha) variant was identified in the United Kingdom in September 2020, researchers determined that the new variant had several genetic alterations: a N501Y mutation, which increased the viral binding affinity with angiotensin-converting–enzyme 2 receptor
1; a H69del/V70del mutation, which was potentially associated with immune evasion and affected S-gene polymerase-chain-reaction (PCR) assays, resulting in S-gene target failure; and a P681H mutation, which potentially facilitated epithelial-cell entry.
2 Direct estimates of the potential of a variant for expansion and increased transmission are limited but have important implications for the global dissemination of these and future SARS-CoV-2 variants.